お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は単純ヘルペスウイルス感染症治療薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは単純ヘルペスウイルス感染症治療薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の単純ヘルペスウイルス感染症治療薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは単純ヘルペスウイルス感染症治療薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に単純ヘルペスウイルス感染症治療薬市場を分類しています。本研究に含まれる主な企業は：F. Hoffmann-La Roche Ltd、Sanofi、Teva Pharmaceuticals Inc、Merck & Co., Inc、Apotex Inc、Viatris、Epi Health LLC、Zydus Pharmaceuticals、GlaxoSmithKline LLC、Carlsbad Tech、Avet Pharmaceuticals Inc、Glenmark Pharmaceuticals、Fresenius Kabi、Agenus, Inc、Maruho Co. Ltd、AiCuris Anti-infective Cures GmbH

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Herpes Simplex Virus-1 (HSV-1) Infection
    Herpes Simplex Virus-2 (HSV-2) Infection
    HSV1 & HSV2 Co-infection

用途別の市場セグメント：
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

本レポートの詳細内容
世界の単純ヘルペスウイルス感染症治療薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、単純ヘルペスウイルス感染症治療薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の単純ヘルペスウイルス感染症治療薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の単純ヘルペスウイルス感染症治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、単純ヘルペスウイルス感染症治療薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

単純ヘルペスウイルス感染症治療薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：単純ヘルペスウイルス感染症治療薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：単純ヘルペスウイルス感染症治療薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章単純ヘルペスウイルス感染症治療薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：単純ヘルペスウイルス感染症治療薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：単純ヘルペスウイルス感染症治療薬の主要企業の概要を提供し、製品の説明と仕様、単純ヘルペスウイルス感染症治療薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. The period of latency and mode of reactivation of HSV is still unclear.
Market Analysis and Insights: Global Herpes Simplex Virus Infection Treatment Market
The global Herpes Simplex Virus Infection Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Herpes Simplex Virus Infection Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Herpes Simplex Virus Infection Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Herpes Simplex Virus Infection Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Herpes Simplex Virus Infection Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Herpes Simplex Virus Infection Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Herpes Simplex Virus Infection Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including F. Hoffmann-La Roche Ltd, Sanofi, Teva Pharmaceuticals Inc, Merck & Co., Inc, Apotex Inc, Viatris, Epi Health LLC, Zydus Pharmaceuticals and GlaxoSmithKline LLC, etc.
Market Segmentation
By Company
    F. Hoffmann-La Roche Ltd
    Sanofi
    Teva Pharmaceuticals Inc
    Merck & Co., Inc
    Apotex Inc
    Viatris
    Epi Health LLC
    Zydus Pharmaceuticals
    GlaxoSmithKline LLC
    Carlsbad Tech
    Avet Pharmaceuticals Inc
    Glenmark Pharmaceuticals
    Fresenius Kabi
    Agenus, Inc
    Maruho Co. Ltd
    AiCuris Anti-infective Cures GmbH

Segment by Type
    By Type
        Herpes Simplex Virus-1 (HSV-1) Infection
        Herpes Simplex Virus-2 (HSV-2) Infection
        HSV1 & HSV2 Co-infection
    By Route of Administration
        Oral
        Parenteral
    By Drug Molecule
        Small Molecule
        Vaccine

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Herpes Simplex Virus Infection Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Simplex Virus Infection Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Simplex Virus Infection Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Herpes Simplex Virus-1 (HSV-1) Infection
    Table 3. Key Players of Herpes Simplex Virus-2 (HSV-2) Infection
    Table 4. Key Players of HSV1 & HSV2 Co-infection
    Table 5. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Herpes Simplex Virus Infection Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Herpes Simplex Virus Infection Treatment Market Share by Region (2019-2024)
    Table 9. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Herpes Simplex Virus Infection Treatment Market Share by Region (2025-2030)
    Table 11. Herpes Simplex Virus Infection Treatment Market Trends
    Table 12. Herpes Simplex Virus Infection Treatment Market Drivers
    Table 13. Herpes Simplex Virus Infection Treatment Market Challenges
    Table 14. Herpes Simplex Virus Infection Treatment Market Restraints
    Table 15. Global Herpes Simplex Virus Infection Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Herpes Simplex Virus Infection Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Herpes Simplex Virus Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2023)
    Table 18. Global Herpes Simplex Virus Infection Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Herpes Simplex Virus Infection Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Herpes Simplex Virus Infection Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Herpes Simplex Virus Infection Treatment, Product and Application
    Table 22. Global Key Players of Herpes Simplex Virus Infection Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Herpes Simplex Virus Infection Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Herpes Simplex Virus Infection Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Herpes Simplex Virus Infection Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Herpes Simplex Virus Infection Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Herpes Simplex Virus Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Herpes Simplex Virus Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Herpes Simplex Virus Infection Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Herpes Simplex Virus Infection Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Herpes Simplex Virus Infection Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Herpes Simplex Virus Infection Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Herpes Simplex Virus Infection Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Herpes Simplex Virus Infection Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Herpes Simplex Virus Infection Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. F. Hoffmann-La Roche Ltd Company Details
    Table 65. F. Hoffmann-La Roche Ltd Business Overview
    Table 66. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product
    Table 67. F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 68. F. Hoffmann-La Roche Ltd Recent Developments
    Table 69. Sanofi Company Details
    Table 70. Sanofi Business Overview
    Table 71. Sanofi Herpes Simplex Virus Infection Treatment Product
    Table 72. Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 73. Sanofi Recent Developments
    Table 74. Teva Pharmaceuticals Inc Company Details
    Table 75. Teva Pharmaceuticals Inc Business Overview
    Table 76. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product
    Table 77. Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 78. Teva Pharmaceuticals Inc Recent Developments
    Table 79. Merck & Co., Inc Company Details
    Table 80. Merck & Co., Inc Business Overview
    Table 81. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product
    Table 82. Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 83. Merck & Co., Inc Recent Developments
    Table 84. Apotex Inc Company Details
    Table 85. Apotex Inc Business Overview
    Table 86. Apotex Inc Herpes Simplex Virus Infection Treatment Product
    Table 87. Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 88. Apotex Inc Recent Developments
    Table 89. Viatris Company Details
    Table 90. Viatris Business Overview
    Table 91. Viatris Herpes Simplex Virus Infection Treatment Product
    Table 92. Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 93. Viatris Recent Developments
    Table 94. Epi Health LLC Company Details
    Table 95. Epi Health LLC Business Overview
    Table 96. Epi Health LLC Herpes Simplex Virus Infection Treatment Product
    Table 97. Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 98. Epi Health LLC Recent Developments
    Table 99. Zydus Pharmaceuticals Company Details
    Table 100. Zydus Pharmaceuticals Business Overview
    Table 101. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product
    Table 102. Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 103. Zydus Pharmaceuticals Recent Developments
    Table 104. GlaxoSmithKline LLC Company Details
    Table 105. GlaxoSmithKline LLC Business Overview
    Table 106. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product
    Table 107. GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 108. GlaxoSmithKline LLC Recent Developments
    Table 109. Carlsbad Tech Company Details
    Table 110. Carlsbad Tech Business Overview
    Table 111. Carlsbad Tech Herpes Simplex Virus Infection Treatment Product
    Table 112. Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 113. Carlsbad Tech Recent Developments
    Table 114. Avet Pharmaceuticals Inc Company Details
    Table 115. Avet Pharmaceuticals Inc Business Overview
    Table 116. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product
    Table 117. Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 118. Avet Pharmaceuticals Inc Recent Developments
    Table 119. Glenmark Pharmaceuticals Company Details
    Table 120. Glenmark Pharmaceuticals Business Overview
    Table 121. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product
    Table 122. Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 123. Glenmark Pharmaceuticals Recent Developments
    Table 124. Fresenius Kabi Company Details
    Table 125. Fresenius Kabi Business Overview
    Table 126. Fresenius Kabi Herpes Simplex Virus Infection Treatment Product
    Table 127. Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 128. Fresenius Kabi Recent Developments
    Table 129. Agenus, Inc Company Details
    Table 130. Agenus, Inc Business Overview
    Table 131. Agenus, Inc Herpes Simplex Virus Infection Treatment Product
    Table 132. Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 133. Agenus, Inc Recent Developments
    Table 134. Maruho Co. Ltd Company Details
    Table 135. Maruho Co. Ltd Business Overview
    Table 136. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product
    Table 137. Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 138. Maruho Co. Ltd Recent Developments
    Table 139. AiCuris Anti-infective Cures GmbH Company Details
    Table 140. AiCuris Anti-infective Cures GmbH Business Overview
    Table 141. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product
    Table 142. AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)
    Table 143. AiCuris Anti-infective Cures GmbH Recent Developments
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Herpes Simplex Virus Infection Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Herpes Simplex Virus-1 (HSV-1) Infection Features
    Figure 4. Herpes Simplex Virus-2 (HSV-2) Infection Features
    Figure 5. HSV1 & HSV2 Co-infection Features
    Figure 6. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Herpes Simplex Virus Infection Treatment Report Years Considered
    Figure 12. Global Herpes Simplex Virus Infection Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Herpes Simplex Virus Infection Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Herpes Simplex Virus Infection Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Herpes Simplex Virus Infection Treatment Market Share by Players in 2023
    Figure 16. Global Top Herpes Simplex Virus Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infection Treatment Revenue in 2023
    Figure 18. North America Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Herpes Simplex Virus Infection Treatment Market Share by Type (2019-2030)
    Figure 20. North America Herpes Simplex Virus Infection Treatment Market Share by Application (2019-2030)
    Figure 21. North America Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)
    Figure 22. United States Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Herpes Simplex Virus Infection Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Herpes Simplex Virus Infection Treatment Market Share by Type (2019-2030)
    Figure 26. Europe Herpes Simplex Virus Infection Treatment Market Share by Application (2019-2030)
    Figure 27. Europe Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)
    Figure 28. Germany Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Herpes Simplex Virus Infection Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Herpes Simplex Virus Infection Treatment Market Share by Type (2019-2030)
    Figure 36. China Herpes Simplex Virus Infection Treatment Market Share by Application (2019-2030)
    Figure 37. Asia Herpes Simplex Virus Infection Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Herpes Simplex Virus Infection Treatment Market Share by Type (2019-2030)
    Figure 39. Asia Herpes Simplex Virus Infection Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Herpes Simplex Virus Infection Treatment Market Share by Region (2019-2030)
    Figure 41. Japan Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)
    Figure 51. Brazil Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 58. Sanofi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 59. Teva Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 60. Merck & Co., Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 61. Apotex Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 62. Viatris Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 63. Epi Health LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 64. Zydus Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 65. GlaxoSmithKline LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 66. Carlsbad Tech Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 67. Avet Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 68. Glenmark Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 69. Fresenius Kabi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 70. Agenus, Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 71. Maruho Co. Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 72. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed